What’s Hot in 2026: Organoids Unbound

From models to living systems, next-generation organoids are on the rise 

The momentum behind New Approach Methodologies (NAMs) has surged this year, gaining significant traction across science, society, and regulatory bodies. A milestone moment came when the first IND application in oncology—whose efficacy data relied entirely on human vascularized organoids—received FDA approval. As drug discovery and development accelerate the adoption of NAMs, organoids themselves are entering a transformative era.

Tumor models, for instance, are rapidly evolving from simple epithelial cultures into immune and vascular-competent tumor organoids¹. These systems now capture the full complexity of the tumor microenvironment (TME)—including stromal cells such as Cancer-Associated Fibroblasts (CAFs), extracellular matrix (ECM), vasculature, and diverse immune infiltrates, all derived from the same donor. These next-gen systems can finally model the complex interplay between tumor and immune cells, enabling more accurate predictions of patient response.

Similarly, liver organoids are reaching an unprecedented physiology. Recent models exhibit complete metabolic zonation, recapitulating the three liver’s metabolic zones, and even organ-specific vasculature—edging closer to transplant-grade tissues^2,3. Some strategies successfully integrate blood-vessel networks via the co-differentiation of mesoderm and endoderm, and 3D bioprinting^{4, 5}.

Across disciplines—from oncology to toxicology to regenerative medicine—the growing cellular complexity of organoids, combined with computational modeling, is enhancing the translational power, making the future in vitro-to-patient bridge more robust than ever.

Next-generation organoids are coming!

-Tania Martianez Canales, PhD, Senior Scientist and Ludovico Buti, PhD, Senior Research Leader, Charles River

Bibliography
1.    Polak et al. Cancer organoids 2.0: modelling the complexity of the tumor immune microenvironment. Nat Rev Cancer (2024).
2.    Al Reza, Takebe et al. Multi-zonal liver organoids from human pluripotent stem cells. Nature (Apr 16, 2025)
3.    Saiki, Takebe et al. Recreating Hepatic Sinusoidal Vasculature in 3D Organoids. Nat Biomed Eng (2025)
4.    Quintard et al. Pancreatic islet spheroids with mesoderm–endoderm co-differentiation integrates perfusable vasculature. Nat Commun (2024).
5.    Gu, Miao, Kotton, et al. Co-development of mesoderm and endoderm enables organotypic vascularization in lung and gut organoids. Cell (2025).